Skip to main content

and
  1. Article

    Open Access

    Efficacy of chemotherapy plus immune checkpoint inhibitors in patients with non-small cell lung cancer who have rare oncogenic driver mutations: a retrospective analysis

    Targeted therapy is now the standard of care in driver–oncogene-positive non-small cell lung cancer (NSCLC). Its initial clinical effects are remarkable. However, almost all patients experience treatment resis...

    Teppei Yamaguchi, Junichi Shimizu, Reiko Matsuzawa, Naohiro Watanabe in BMC Cancer (2024)

  2. Article

    Open Access

    The first case of SMARCB1 (INI1) - deficient squamous cell carcinoma of the pleura: a case report

    SMARCB1 (INI1) is a tumor-suppressor gene located at 22q11.2. Loss of SMARCB1 protein expression has been reported to be associated with atypical teratoid/rhabdoid tumors and malignant rhabdoid tumors of the kidn...

    Kazushi Yoshida, Yutaka Fujiwara, Yasushi Goto, Takashi Kohno in BMC Cancer (2018)